BPMC Annual Total Long Term Liabilities
$703.72 M
+$51.73 M+7.93%
31 December 2023
Summary:
As of January 22, 2025, BPMC annual total long term liabilities is $703.72 million, with the most recent change of +$51.73 million (+7.93%) on December 31, 2023. During the last 3 years, it has risen by +$586.22 million (+498.89%). BPMC annual total long term liabilities is now at all-time high.BPMC Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BPMC Quarterly Long Term Liabilities
$628.84 M
-$10.68 M-1.67%
30 September 2024
Summary:
As of January 22, 2025, BPMC quarterly total long term liabilities is $628.84 million, with the most recent change of -$10.68 million (-1.67%) on September 30, 2024. Over the past year, it has dropped by -$76.46 million (-10.84%). BPMC quarterly long term liabilities is now -10.84% below its all-time high of $705.30 million, reached on September 30, 2023.BPMC Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BPMC Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.9% | -10.8% |
| 3 y3 years | +498.9% | +0.4% |
| 5 y5 years | +1057.6% | +0.4% |
BPMC Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +434.2% | -10.8% | +404.6% |
| 5 y | 5-year | at high | +498.9% | -10.8% | +468.9% |
| alltime | all time | at high | >+9999.0% | -10.8% | +8032.9% |
Blueprint Medicines Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $628.84 M(-1.7%) |
| June 2024 | - | $639.52 M(+22.7%) |
| Mar 2024 | - | $521.18 M(-25.9%) |
| Dec 2023 | $703.72 M(+7.9%) | $703.72 M(-0.2%) |
| Sept 2023 | - | $705.30 M(+12.6%) |
| June 2023 | - | $626.29 M(-1.1%) |
| Mar 2023 | - | $633.39 M(-2.9%) |
| Dec 2022 | $651.99 M(+395.0%) | $651.99 M(+1.5%) |
| Sept 2022 | - | $642.58 M(+124.7%) |
| June 2022 | - | $285.94 M(+129.5%) |
| Mar 2022 | - | $124.62 M(-5.4%) |
| Dec 2021 | $131.72 M(+12.1%) | $131.72 M(+19.2%) |
| Sept 2021 | - | $110.54 M(-3.5%) |
| June 2021 | - | $114.59 M(+1.5%) |
| Mar 2021 | - | $112.93 M(-3.9%) |
| Dec 2020 | $117.50 M(-14.1%) | $117.50 M(-8.3%) |
| Sept 2020 | - | $128.07 M(-2.2%) |
| June 2020 | - | $131.00 M(-1.1%) |
| Mar 2020 | - | $132.40 M(-3.3%) |
| Dec 2019 | $136.85 M | $136.85 M(+7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $127.44 M(-4.1%) |
| June 2019 | - | $132.84 M(-2.1%) |
| Mar 2019 | - | $135.69 M(+123.2%) |
| Dec 2018 | $60.79 M(+24.4%) | $60.79 M(+0.4%) |
| Sept 2018 | - | $60.53 M(-2.1%) |
| June 2018 | - | $61.85 M(+15.4%) |
| Mar 2018 | - | $53.60 M(+9.7%) |
| Dec 2017 | $48.88 M(+18.6%) | $48.88 M(+12.7%) |
| Sept 2017 | - | $43.39 M(+15.3%) |
| June 2017 | - | $37.64 M(-2.7%) |
| Mar 2017 | - | $38.67 M(-6.2%) |
| Dec 2016 | $41.20 M(+153.1%) | $41.20 M(-10.0%) |
| Sept 2016 | - | $45.76 M(-1.0%) |
| June 2016 | - | $46.20 M(-12.1%) |
| Mar 2016 | - | $52.57 M(+222.9%) |
| Dec 2015 | $16.28 M(+110.5%) | $16.28 M(-8.8%) |
| Sept 2015 | - | $17.86 M(-11.5%) |
| June 2015 | - | $20.17 M(+21.8%) |
| Mar 2015 | - | $16.56 M(+114.1%) |
| Dec 2014 | $7.73 M(+212.0%) | $7.73 M |
| Dec 2013 | $2.48 M | - |
FAQ
- What is Blueprint Medicines annual total long term liabilities?
- What is the all time high annual total long term liabilities for Blueprint Medicines?
- What is Blueprint Medicines annual total long term liabilities year-on-year change?
- What is Blueprint Medicines quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Blueprint Medicines?
- What is Blueprint Medicines quarterly long term liabilities year-on-year change?
What is Blueprint Medicines annual total long term liabilities?
The current annual total long term liabilities of BPMC is $703.72 M
What is the all time high annual total long term liabilities for Blueprint Medicines?
Blueprint Medicines all-time high annual total long term liabilities is $703.72 M
What is Blueprint Medicines annual total long term liabilities year-on-year change?
Over the past year, BPMC annual total long term liabilities has changed by +$51.73 M (+7.93%)
What is Blueprint Medicines quarterly total long term liabilities?
The current quarterly long term liabilities of BPMC is $628.84 M
What is the all time high quarterly long term liabilities for Blueprint Medicines?
Blueprint Medicines all-time high quarterly total long term liabilities is $705.30 M
What is Blueprint Medicines quarterly long term liabilities year-on-year change?
Over the past year, BPMC quarterly total long term liabilities has changed by -$76.46 M (-10.84%)